Public-registry trials using Olatorepatide that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes | Regeneron Pharmaceuticals | Overweight or Obesity | PHASE2 | 0 |
| First registered study | February 2026 — NCT07431086 (Regeneron Pharmaceuticals) |
| Registered studies matching this name | 2 all-time · 0 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Trialed alongside
Other Overweight or Obesity drugs
← Eichor home · All tracked trials · Overweight or Obesity studies · Weekly briefs